CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?

Oncoimmunology. 2012 May 1;1(3):364-365. doi: 10.4161/onci.18614.

Abstract

Lymphocytic infiltration is often seen in breast cancer and has been suggested as a marker of host anti-tumor response but its importance in prognosis remains controversial. Our recent study demonstrated an association between tumor-infiltrating CD8(+) T lymphocytes in invasive breast cancer and better prognosis.